Our data illustrated no significant differences in the total percentages of NK cells between our three groups; only the in-depth analysis of AML cases revealed a heterogeneous distribution, with extreme values, as represented by the cases with FLT3-ITD, NPM1, and IDH2 mutations. The gene discussed is NPM1; the disease is acute myeloid leukemia.